Aller au contenu

Publications scientifiques

  • article Niazi T, Nabid A, Malagon T, Tisseverasinghe S, Bettahar R, Dahmane R, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Mohiuddin M

    Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial

    Eur Urol 87 (3), 2025.

    DOI PUBMED
  • article Nabid A, Carrier N, Martin AG, Bahary JP, Vavassis P, Vass S, Bahoric B, Archambault R, Vincent F, Bettahar R, Souhami L

    Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial

    Qual Life Res 34 (3), 2025.

    DOI PUBMED
  • article Niazi T, Nabid A, Malagon T, Bettahar R, Vincent L, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Tsui JMG, Mohiuddin M

    Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinair…

    Int J Radiat Oncol Biol Phys 118 (1), 2024.

    DOI PUBMED
  • article Spyrou A, Martin AG, Hannoun-Lévi JM, Stewart A

    Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how

    Clin Transl Radiat Oncol 49 2024.

    DOI PUBMED
  • article Vuong T, Garant A, Vendrely V, Nout R, Martin AG, Enger SA, Podgorsak E, Moftah B, Devic S

    Image-Guided Brachytherapy for Rectal Cancer: Reviewing the Past Two Decades of Clinical Investigation

    Cancers (Basel) 14 (19), 2022.

    DOI PUBMED
  • article Garant A, Vasilevsky CA, Boutros M, Khosrow-Khavar F, Kavan P, Diec H, Des Groseilliers S, Faria J, Ferland E, Pelsser V, Martin AG, Devic S, Vuong T

    MORPHEUS Phase II-III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results

    Cancers (Basel) 14 (15), 2022.

    DOI PUBMED
  • article Pollack A, Karrison TG, Balogh AG, Gomella LG, Low DA, Bruner DW, Wefel JS, Martin AG, Michalski JM, Angyalfi SJ, Lukka H, Faria SL, Rodrigues GB, Beauchemin MC, Lee RJ, Seaward SA, Allen AM, Monitto DC, Seiferheld W, Sartor O, Feng F, Sandler HM

    The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre,…

    Lancet 399 (10338), 2022.

    DOI PUBMED
  • article Khriguian J, Tsui JMG, Vaughan R, Kucharczyk MJ, Nabid A, Bettahar R, Vincent L, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Mohiuddin M, Niazi T

    The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients

    J Urol 205 (6), 2021.

    DOI PUBMED
  • article Nabid A, Carrier N, Martin AG, Bahary JP, Lemaire C, Vass S, Bahoric B, Archambault R, Vincent F, Bettahar R, Duclos M, Garant MP, Souhami L

    Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial

    Eur Urol 74 (4), 2018.

    DOI PUBMED
  • article Tiberi D, Rodrigues G, Pickles T, Morris J, Crook J, Martin AG, Cury F, Catton C, Lukka H, Warner A, Taussky D

    Supplementary data: External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer

    Can Urol Assoc J 11 (3-4), 2017.

    DOI
  • article Tiberi D, Rodrigues G, Pickles T, Morris J, Crook J, Martin AG, Cury F, Catton C, Lukka H, Warner A, Taussky D

    External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer

    Can Urol Assoc J 11 (3-4), 2017.

    DOI PUBMED
  • chapitre Martin AG, Lacroix F, Niedermayr T, Nguyen PL

    Genitourinary Brachytherapy

    In: Devlin PM and Stewart AJ and Cormack RA and Holloway CL (ed.): (Brachytherapy : applications and techniques), p. 2015, ISBN: 9781620700822, .